"Cancer Perspectives And Recent Advances In Anti-Cancer Drug Research: A Review In The Lens Of Siddha Medicine"
Main Article Content
Abstract
Introduction: Cancer is a global health challenge, demanding innovative approaches for prevention, diagnosis, and treatment. Despite ongoing research efforts, finding a definitive cure for cancer remains a formidable challenge. In response to these challenges, the concept of integrative oncology has gained prominence, aiming to combine conventional treatments with evidence-based complementary therapies.
Objective: This review explores the integration of Siddha medicine, an ancient South Indian system, with modern oncology to offer holistic cancer care. Siddha perspectives on cancer, its classifications, etiopathogenesis, diagnostic methodologies, and treatment modalities are thoroughly analysed in comparison with modern approach. Recent research on Siddha medicines demonstrating anti-cancer potential is also being reviewed through a systematic literature analysis.
Methodology: Analyses of various Siddha texts is done to know the terminologies and categories of cancer. Siddha's etiopathogenesis, diagnostic methodologies and Siddha treatment modalities are discussed, emphasizing the balance of humours. Recent research on Siddha medicines for cancer treatment is compiled through a systematic literature review.
Discussion: The manuscript decodes Siddha's conceptual framework underlying cancer hallmarks, aligning Vatham, Pitham, and Kabam with the eight hallmark capabilities. Siddha diagnostic methodologies, including pulse reading and urine examination, are compared with modern techniques. Siddha treatment modalities, rooted in herbal formulations, are presented. A comprehensive compilation of Siddha drugs with anti-cancer potential is provided, supported by in-vitro, in-vivo, and clinical studies.
Conclusion: The multifaceted nature of cancer necessitates a comprehensive approach, and Siddha medicine provides unique insights. While Siddha may not directly align with modern diagnostics, its holistic principles contribute valuably to cancer discussions. Integrating Siddha into mainstream oncology requires scientific rigor, with further research and clinical trials to validate safety and efficacy. The fusion of Siddha wisdom with modern oncology holds promise for a more holistic and patient-centric cancer care approach.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
https://www.who.int/news-room/fact-sheets/detail/cancer accessed on 07.12.2023.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660.
Madihalli Somashekharaiah Chandraprasad, Abhijit Dey, Mallappa Kumara Swamy,1 - Introduction to cancer and treatment approaches,Editor(s): Mallappa Kumara Swamy, T. Pullaiah, Zhe-Sheng Chen,Paclitaxel,Academic Press,2022,Pages 1-27.
Bhala N, Ferguson JW, Rajoriya N, Newsome PN. Using globalburden of hepatocellular cancer and liver cirrhosis as a driver totackle preventable mortality and morbidity nationallyandregionally. Hepatology 2023;77(4):1078–1080. Available at: http://doi.org/10.1097/hep.0000000000000011.
Natterson-Horowitz B, Aktipis A, Fox M, et al. The futureof evolutionary medicine: sparking innovation in biomedicineandpublic health. Front Sci 2023;1:997136. Available at: http://doi.org/10.3389/fsci.2023.997136.
Kucukoner M, Bilge Z, Isıkdogan A, Ali Kaplan M, Inal A, UrakciZ. Complementary and Alternative Medicine Usage in CancerPatients in Southeast of Turkey. Afr J Trad Compl Alt Med2012;10(1):21–25. Available at: http://doi.org/10.4314/ajtcam.v10i1.4.
Greenlee H, Kwan ML, Ergas IJ, et al. Complementaryandalternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat 2009;117(3):653–665. Available at:
http://doi.org/10.1007/s10549-009-0315-3.
Lopez G, Mao JJ, Cohen L. Integrative Oncology. Med Clin North Am. 2017 Sep;101(5):977-985. doi:
1016/j.mcna.2017.04.011. Epub 2017 Jun 23. PMID: 28802474.
Sowmyalakshmi S, Nur-E-Alam M, Akbarsha MA, Thirugnanam S, Rohr J, Chendil D. Investigation on Semecarpus Lehyam--a Siddha medicine for breast cancer. Planta. 2005 Apr;220(6):910-8. doi:
1007/s00425-004-1405-4. Epub 2004 Oct 28. PMID: 15517350.
Ketheeswaranathan S, Soruban T. A study of diagnosis and treatment of “Puttru Noi”[cancer] in Siddha and traditional systems of medicine: A literature study. Int J Sci Res (Ahmedabad). 2014;3:625-8.
Lekha GS, Aparna S, Kasirajan N, Kanagarajan A. Diagnosis and Treatment of Cancer–Siddha Perspective. Journal of Research in Siddha Medicine. 2018 Jul 1;1(1):3-14.
Sambasivam Pillai.T.V. Tamil-English Dictionary of Medicine, Chemistry, Botany and Allied Sciences – vol 2. 2nd Ed. Directorate of Indian Medicine and Homeopathy; 1991. p.no.1246-7.
Winslow M. A comprehensive Tamil-English Dictionary. New Delhi: Asian Educational Services; 2011. p.802.
Gladys J, Kalai A, Elangovan S, Mubarak H. Screening of siddha medicinal plants for anti cancer activitya review. J App Pharma Sci 2013; 3(7): 176-182.
Hanahan D, Weinberg RA. Biological hallmarks of cancer. Holland‐Frei Cancer Medicine. 2022;1–10.
Dr.M.Shanmugavelu. Noi Naadal Noi Mudhal Naadal Thirattu Part-I. 6th Ed. Directorate of Indian Medicine and Homeopathy;2014.p.no.24,97,269.
Dr. R. Thiyagarajan. Yugi Vaithya Chindhamani (Tamil), 2nd ed. Chennai:Department of Indian medicine and Homoeopathy, 2005.p.no.245-8.
Pulumati A, Pulumati A, Dwarakanath BS, Verma A, Papineni RV. Technological advancements in cancer diagnostics: Improvements and limitations. Cancer Reports. 2023 Feb;6(2):e1764.
Rathiga G, Raj NG, Chamy PM, Kantham TL, Manikavasagam K, Banumathi V. A Pilot Study on Neikuri Pattern in Carcinoma Patients.World J Pharm Res. 2018 June; 7(12):870-8.
Ganapathy P, Elumalai K, Arumugam MK, Amulya CS, Manivel R. Anticancer potential of Siddha formulations against oral cancer cell line in vitro. Trends in Medicine. 2019;19:1-6.
Priyanka G, Kayalvizhi E, Madan Kumar A, Amulya Y, Manivel R. Chemopreventive effect of maha vallathy leghiyam on 4-Nitroquinoline-1-oxide induced oral carcinogenesis in wistar rats. Int Arch Integr Med. 2019 Jul 1;6:28-36.
Zhao W, Zhu L, Srinivasan S, Damodaran C, Rohr J. Identification of urushiols as the major active principle of the Siddha herbal medicine Semecarpus Lehyam: Anti-tumor agents for the treatment of breast cancer. Pharmaceutical biology. 2009 Sep 1;47(9):886-93.
Riyasdeen A, Periasamy VS, Paul P, Alshatwi AA, Akbarsha MA. Chloroform extract of Rasagenthi Mezhugu, a Siddha formulation, as an evidence-based complementary and alternative medicine for HPVpositive Cervical Cancers. Evidence-Based Complementary and alternative medicine. 2012.
Baskaran J, Gnanamani A, Stanley VA, Stanley SA. Studies on the anticancer potential (GI50) of the siddha formulation, Rasagenthi Mezhugu on human cell lines. Journal of Chemical and Pharmaceutical Research. 2017;9(10):254-7.
Srinivasan MR, Kayalvizhi P, Subathra T, Shanmugapriya P, Sangeetha MK, Nithyamala I, Rajakumar K, Chithra M. In vitro Antiproliferative and Cytotoxic potential of the Siddha formulation-Neeradi Muthu VallathiMezhugu-Against HeLa Cervical cancer cell line. Journal of Survey in Fisheries Sciences. 2023 Mar 18;10(4S):686-93.
Simna SP, Elangovan V. Chemopreventive Effect Of Neeradimuthuvallathy Mezhugu-Siddha Formulation Against 7, 12, Dimethyl Benz [A] Anthracene Induced Skin Carcinogenesis In Swiss Albino Mice. Journal of Pharmacy Research. 2012 Aug;5(8):4307-12.
Semalatha S. Scientific Validation of Anti-cancer, Anti tumour and Anti-oxidant activities of Siddha Herbo-mineral Formulation Bhramasthiram in Various cell lines studies (Doctoral dissertation, Government Siddha Medical College, Chennai).
Girija NS, Neethi B, Sakthimanipriya L, Sinekha MA, Shanmugapriya P, Meenakumari R. In-Vitro Cytotoxic, Antiproliferative and Apoptotic Activity of Siddha Formulation Nandhi Mezhugu (NM) Against Hela Cell Line. Applied Biochemistry and Biotechnology. 2023 Jul 12:1-1.
Francis GA, Arumugam S, Krishnan SG, Murugan R, Johnson CG, Christian ME, Ramasamy M. In vitro Anti-cancer Activity of Nandhi mezhugu (NM) in Ovarian Cancer Cell Line (PA-1) Using MTT Assay. International Journal of Pharmaceutical Investigation. 2023 Jul 1;13(3).
Ravichandran N, Rajalakshmi P, Davidraj C, Arun KP, Brindha P. Standardization and in vitro cytotoxic studies on Narasimha lehiyam: A potent anticancer Siddha drug. Asian Journal of Chemistry. 2014 Jun 15;26(12):3692.
Ranga RS, Girija R, Nur-e-Alam M, Sathishkumar S, Akbarsha MA, Thirugnanam S, Rohr J, Ahmed MM, Chendil D. Rasagenthilehyam (RL) a novel complementary and alternative medicine for prostate cancer. Cancer chemotherapy and pharmacology. 2004 Jul;54:7-15.
Meenakumari R. Siddha management for Squamous cell Gingivobuccal carcinoma (Kannaputru) reporting at cancer special OPD of National Institute of Siddha-A single case report. Journal of Research in Biomedical Sciences. 2023 Jun 30;5(2):379-82.
Kumudha V, Mohammed Musthafa M. Invitro Anti-Cancer Activity of Siddha Herbal Formulation Kodiveli Chooranam Against Colorectal Cancer. World Journal of Pharmaceutical Research. 2018 Oct; 7(18): 964-969.
Rajalakshmi S, Musthafa MM, Isai M, Sathiyarajeswaran P. A Comparative study to evaluate the anticancer activity of siddha drugs “Veera Rasa Padhangam” and “PanchamugaChendhuram” with the standard drug taxol. Int. J. Curr. Res. Chem. Pharm. Sci. 2017;4(12):29-33.
Nisha J, Elakkiyaa V, Anbu N, Visweswaran S, Muthukumar NJ. In-Vitro Anti-Cancer Evaluation of Siddha formulation Sathakuppai Chooranam (SKC) against HeLa (cervical adenocarcinoma) cell line by MTT assay. Journal of Pharmaceutical Sciences and Research. 2019 Dec 1;11(12):3773-6.
Balakrishnan K, Arumugam S, Magesan G. Design, Development and Performance Evaluation of Nano Robot in Traditional Siddha Medicines for Cancer Treatment. Journal of ICT Standardization. 2020 Jul 9:217-34.
Vaniswari DS, Arunachalam K. Anti-Oxidant and Anti-Cancer Potential of Siddha Medicine Thayiriya Vendhan Chendhuram (TVC) using MTT Assay against MCF-7 (Human Breast Adenocarcinoma). Journal of Medical Science and Clinical Research. 2019;7(5):690-4.
Megala K. Scientific Validation of Siddha Herbo Mineral Formulation “GandhagaPooraParpam” for its Anti-Cancer, Anti-Tumour-Apoptosis Inducing Effects in HeLa and SiHa Cell Line Models and In vitro Anti-Oxidant Activity (Doctoral dissertation, Government Siddha Medical College, Chennai).
Janani S. Scientific Validation of Siddha Herbomineral Formulation Naaga Chendooram for Anti-Cancer Activity, Apoptosis inducing Potential (Anti Tumour) in MCF-7 and MDA-MB 231 Cell Lines and Antioxidant Activity using In-Vitro Methods (Doctoral dissertation, Government Siddha Medical College, Chennai).
Kaviya V. Anti-Cancer Activity of Siddha Drug Ashta BairavaChenduram against Oral Squamous Cell Carcinoma [OSCC] through In-Vitro Model (Doctoral dissertation, Government Siddha Medical College, Chennai).
Deepa G. Scientific Validation of Potent Anti-cervical cancer, Anti-tumor and Anti-oxidant activities of Siddha Herbo Mineral Formulation Rasa Parpam in in-vitro studies (Doctoral dissertation, Government Siddha Medical College, Chennai).
Vimala R. Scientific Validation of Siddha Herbo-Metallic Formulation Kandha Rasa Villai to Evaluate the Efficacy of it’s Anti-Cancer, Anti-Tumour and Anti-Oxidant Activities (Doctoral dissertation, Government Siddha Medical College, Chennai).
Abinaya R. Scientific Validation of Anti-Oral Cancer, Anti-Tumour, Antimicrobial Activities of Siddha Metallo-Mineral Formulation Kaalamega Narayana Chendhooram in Cell Line Studies (Doctoral dissertation, Government Siddha Medical College, Chennai).
Kumari HV, Manickavasakam K. The Combined Effect of Siddha Medicines in the Treatment of NaakkuPutru Noi (Squamous Cell Carcinoma of the Tongue). International Journal of Pharmacy and Pharmaceutical Sciences. 2013 Dec 30; 6(Suppl 1):38-9.
Karanath-Anilkumar A, Munuswamy-Ramanujam G, Soman V, Munusamy SD, Sampangiramulu SP. Evaluation of Cytotoxic Potential of Classical Siddha Medicine Padikara Parpam in Human Monocytic Leukemic Cell Lines (THP-1). Ind. J. Pharm. Edu. Res. 2023;57(3s):s639-43.
Kayalvizhi S, Saravanan AS. Anticancer Activity of Thambira Chendhuram In Kb (Oral Carcinoma) Cell Line In Vitro Method. Int. J. Novel Res. And Development.2023;8(3):a500-6.
Suja RM, Williams BC. Cytotoxic And Antiproliferative Activity of Adaikamani Thailam Prescribed to Cure Breast Cancer, India.World Journal of Pharmacy and Pharmaceutical Sciences.2023;6(1),607-619.
Saraswathy S. Anti-Cancer Activiy of Namachivaya Chendooram in In-Vitro Cell Line Models Against Invasive Cervical Carcinoma (Doctoral dissertation, Government Siddha Medical College, Chennai).
Saraswathy S. Anti-Cancer Activiy of Namachivaya Chendooram in In-Vitro Cell Line Models Against Invasive Cervical Carcinoma (Doctoral dissertation, Government Siddha Medical College, Chennai).
Suja RM, Williams BC. In-Vitro Antiproliferative Effect of Cancer Medicine Karumsurathi Thailam on Cultured MCF-7 Cell Line. Int J of Sci and Research. 2017 Jan; 6(1):1271-4.
Ravichandran M, Mubarak H. In-Vitro Anti Proliferative, Antioxidant and Phytochemical Screening of a Siddha Drug Chithiramoola Kuligai. World J. pharm. And pharmaceutical Sciences.2014;3(8):1117-1127.
Ravichandran M, Mubarak H. Evaluation of phytochemical and in vitro anti-oxidant, anti proliferative activity of a polyherbal Siddha formulation Vallarai nei. Int. J. Curr. Microbiol. App. Sci. 2014;3(4):16171.
Karthikraja S. Pre-Clinical Study of Herbo Mineral Formulation Rasa Karpoora Kuligai for its AntiCancer, Anti-Oxidant and Anti-Inflammatory Activities (Doctoral dissertation, Government Siddha Medical College, Palayamkottai).
Indhu PM. Standardization and Pharmacological profile of Vithu Rasa Mezhugu for its Anti-arthritic, Invitro Anti-cancer and Anti-microbial activities (Doctoral dissertation, National Institute of Siddha, Chennai).
Vinutha T, Manekshah YR. Determination of In-vitro Anticancer activity of ‘’Vembu Karpam’’-a hundred years old bark based Siddha Medicine. Journal of Research in Biomedical Sciences. 2019 May 28;1(1):37-41.
Nandhini E, Chakravarthi P, Kanimozhi S, Ponmalar E. In Vitro Anti-Cancerous Activity of Navamani Chenduram (Nmc) In Ovarian Cancer Cell Line (PA-1) Using MTT Assay. Int. J. Sci. Academic Research.2023;4(9):6177-6181.
Soruban T. Standardization and Pharmacological Evaluation of Linga Chenduram (LC) for its Anti Cancerous, Chronic Anti Inflammatory and Analgesic activities (Doctoral dissertation, National Institute of Siddha, Chennai).
Babu P, Anbu J, Ashwinianjana VV. Anti tumour activity of Guru Pathangam against Dalton ascites Lymphoma (dal) in Mice. International Journal of Pharma and Bio Sciences. 2012;3(3):281-9.
Rajanandhini M, Mohammed Musthafa M. Anti proliferative effect of Herbo mineral formulation Pancha Pashana Chendhuram in cervical cancer cells. Int. J. Curr. Res. Chem. Pharm. Sci. 2017;4(7):34-7.
Periasamy VS, Subash-Babu P, Muthukumaran VR, Akbarsha MA, Alshatwi AA. In Vitro Cytotoxic Effect of Formulated Semecarpus Ghee Nanoemulsion on Human Cervical Cancer (SiHa) Cells. Advanced Science Letters. 2012 Mar 15;6(1):75-9.
Nisha MA, Preetha S, Selvaraj J, Sridevi G. Effect of Kabasura Kudineer Extract on Inflammatory
Cytokines [Interleukin-6 and Tumour Necrosis Factor-α] in Lung Cancer Cell Line A549. Journal of Pharmaceutical Research International. 2021 Nov 4;33(47B):653-60.
Kanchana K, Shanthi P, Sachdanandam P. Anticarcinogenic activity of kalpaamruthaa, a modified Siddha preparation, against aflatoxin–B 1-induced hepatocellular carcinoma in rats. Comparative Clinical Pathology. 2014 Sep;23:1283-92.